ABEO
ABEO
NASDAQ · Biotechnology

Abeona Therapeutics Inc

$4.29
-0.04 (-0.92%)
As of Mar 29, 10:31 PM ET ·
Financial Highlights (FY 2026)
Revenue
4.88M
Net Income
59.75M
Gross Margin
73.7%
Profit Margin
1,223.1%
Rev Growth
+60.4%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.7% 73.7% 45.4% 45.4%
Operating Margin 1,081.1% 973.0% -8.6% -10.0%
Profit Margin 1,223.1% 1,161.9% -11.2% -11.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.88M 3.05M 39.71M 32.89M
Gross Profit 3.60M 2.24M 18.02M 14.92M
Operating Income 52.81M 29.63M -3,427,237 -3,280,542
Net Income 59.75M 33.52M -4,431,314 -3,676,832
Gross Margin 73.7% 73.7% 45.4% 45.4%
Operating Margin 1,081.1% 973.0% -8.6% -10.0%
Profit Margin 1,223.1% 1,161.9% -11.2% -11.2%
Rev Growth +60.4% +60.4% +12.5% +7.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 13.80M 13.80M 47.63M 42.47M
Total Equity 109.71M 109.71M 217.43M 201.44M
D/E Ratio 0.13 0.13 0.22 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 60.45M 35.80M -4,969,444 -4,544,257
Free Cash Flow -4,447,710 -3,857,678